Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Shares Issued (2020 - 2025)

Black Diamond Therapeutics (BDTX) has disclosed Shares Issued for 2 consecutive years, with $64000.0 as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Shares Issued fell 99.97% year-over-year to $64000.0, compared with a TTM value of $729000.0 through Dec 2021, down 33.73%, and an annual FY2024 reading of $1.1 million, down 98.53% over the prior year.
  • Shares Issued was $64000.0 for Q3 2021 at Black Diamond Therapeutics, down from $184000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $213.8 million in Q1 2020 and bottomed at -$213.8 million in Q2 2020.